Shim, JM
21  results:
Search for persons X
?
 
?
2

Randomized phase I trial HIV-CORE 003: Depletion of serum a..:

Borthwick, NJ ; Lane, T ; Moyo, N...
https://discovery.ucl.ac.uk/id/eprint/10049376/1/Gillmore_Randomized%20phase%20I%20trial%20HIV-CORE%20003.%20Depletion%20of%20serum%20amyloid%20P%20component%20and%20immunogenicity%20of%20DNA%20vaccination%20against%20HIV-1_VoR.pdf.  , 2018
 
?
5

P837Gender related differences in management of nonvalvular..:

Lee, JM. ; Kim, TH. ; Cha, MJ....
EP Europace.  19 (2017)  suppl_3 - p. iii153-iii153 , 2017
 
?
6

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid ..:

Pyun JM ; Ryu JS ; Lee R...
https://www.dovepress.com/plasma-amyloid-beta-oligomerization-tendency-predicts-amyloid-pet-posi-peer-reviewed-fulltext-article-CIA.  , 2021
 
?
 
?
9

The physical oceanography of the transport of floating mari..:

van Sebille, E ; Aliani, S ; Law, KL...
http://plymsea.ac.uk/id/eprint/8898/1/van_Sebille_2020_Environ._Res._Lett._15_023003.pdf.  , 2020
 
?
10

SCUBA-2 Ultra Deep Imaging EAO Survey (STUDIES). IV. Spatia..:

Lim, CF ; Chen, CC ; Smail, I...
https://discovery.ucl.ac.uk/id/eprint/10102327/1/Lim_2020_ApJ_895_104.pdf.  , 2020
 
?
11

APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptid..:

Driscoll, CB ; Schuelke, MR ; Kottke, T...
https://eprints.whiterose.ac.uk/156242/3/s41467-020-14568-7.pdf.  , 2020
 
?
12

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy:

Huff, AL ; Wongthida, P ; Kottke, T...
Molecular therapy oncolytics, 2018, 11 pp. 1 - 13.  , 2019
 
?
13

JINGLE, a JCMT legacy survey of dust and gas for galaxy evo..:

Saintonge, A ; Wilson, CD ; Xiao, T...
https://discovery.ucl.ac.uk/id/eprint/10058595/1/Saintonge_JINGLE,%20a%20JCMT%20legacy%20survey%20of%20dust%20and%20gas%20for%20galaxy%20evolution%20studies%20%E2%80%93%20I.%20Survey%20overview%20and%20first%20results_VoR.pdf.  , 2018
 
?
14

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy:

Huff, AL ; Wongthida, P ; Kottke, T...
https://eprints.whiterose.ac.uk/139959/1/APOBEC3%20Mediates%20Resistance%20to%20Oncolytic%20Viral%20Therapy.pdf.  , 2018
 
1-15